FRATI, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 3.279
EU - Europa 3.030
AS - Asia 1.368
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
SA - Sud America 3
Totale 7.704
Nazione #
US - Stati Uniti d'America 3.242
CN - Cina 947
IT - Italia 609
IE - Irlanda 600
SE - Svezia 536
FI - Finlandia 509
DE - Germania 268
SG - Singapore 253
UA - Ucraina 186
FR - Francia 112
TR - Turchia 110
AT - Austria 73
BE - Belgio 41
GB - Regno Unito 35
CA - Canada 34
IN - India 32
CZ - Repubblica Ceca 26
CI - Costa d'Avorio 14
NL - Olanda 12
VN - Vietnam 10
EU - Europa 6
JP - Giappone 6
HK - Hong Kong 4
CH - Svizzera 3
ES - Italia 3
IR - Iran 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AU - Australia 2
BR - Brasile 2
LT - Lituania 2
PL - Polonia 2
RO - Romania 2
BS - Bahamas 1
BT - Bhutan 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
IS - Islanda 1
MT - Malta 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 7.704
Città #
Chandler 623
Dublin 600
Parma 314
Jacksonville 247
Ann Arbor 246
Dearborn 242
Ashburn 224
Boardman 196
Nanjing 162
Beijing 154
Singapore 143
Shanghai 124
Princeton 101
Wilmington 101
Izmir 95
New York 90
Bremen 74
Vienna 69
Jinan 56
Padova 56
Nanchang 53
Helsinki 51
San Mateo 51
Seattle 50
Brussels 41
Shenyang 41
Des Moines 37
Kunming 35
Hebei 33
Changsha 32
Hefei 31
Toronto 26
Tulsa 26
Jiaxing 20
Woodbridge 20
Guangzhou 18
Fremont 16
Houston 16
Norwalk 16
Zhengzhou 15
Abidjan 14
Kocaeli 14
Munich 14
Pune 14
Tianjin 14
Haikou 13
Los Angeles 13
Marseille 13
Ningbo 13
Dallas 12
Rio Saliceto 12
Chicago 11
Hangzhou 11
Lanzhou 11
Dong Ket 10
Milan 10
Modena 10
Monmouth Junction 10
Olomouc 10
Santa Clara 10
Taizhou 10
Brno 9
Amsterdam 8
Taiyuan 8
Falls Church 7
Redwood City 7
Düsseldorf 6
Fuzhou 6
Grafing 6
Bologna 5
Chengdu 5
Redmond 5
Rockville 5
Rome 5
Washington 5
Ardea 4
Busseto 4
Genova 4
Leawood 4
Mirandola 4
Borgonovo Val Tidone 3
Bratislava 3
Edinburgh 3
Frankfurt am Main 3
Mumbai 3
Napoli 3
Pavia 3
Piacenza 3
Strasbourg 3
Tappahannock 3
Torre Annunziata 3
Ardabil 2
Assago 2
Augusta 2
Bangalore 2
Belgrade 2
Candiac 2
Carpi 2
Castro del Rio 2
Changchun 2
Totale 4.952
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 175
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 156
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 152
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 148
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 142
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 138
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 133
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 127
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 124
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 116
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 115
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 107
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats 106
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 102
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 102
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 100
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 98
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 97
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 97
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 96
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 96
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 90
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 90
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 89
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 86
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 86
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 86
Isolation and characterization of human lung lymphatic endothelial cells 86
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 85
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 84
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 83
Electromechanical competence of the myocardium regenerated by growth factors and cell therapy in ischemic cardiomyopathy. 82
Studio in vitro ed in vivo della biocompatibilità di PAM (pharmacologically active microcarriers) come substrato per la rigenerazione miocardica 81
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 80
High-Resolution X-Ray Microtomography for Three-Dimensional Visualization of Cardiac Progenitor Cells Homing in Infarcted Rat Hearts 80
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 80
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 80
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 79
Resident cardiac stem cells. 79
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 79
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 78
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 78
Assessment of Cardiac Patches Suitability for Tissue Engineering 77
Stem cells and myocardial regeneration 76
Effetti del Growth Hormone sulla riparazione dell’infarto miocardico acuto. 75
Functional recovery of the infarcted heart mediated by pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors 75
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients 75
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 74
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 73
Characterization of ABC transporters in epiairway™, a cellular model of normal human bronchial epithelium 73
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 70
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 70
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico 70
Role of cardiac lymphatic vessels in ischemic and drug induced cardiomyopathy 70
Electrical stability of infarcted rat hearts following treatment with stem cells 69
Cellule mesenchimali placentari: una risorsa per la vasculogenesi 69
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 69
Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans. 68
Bioactive Electrospun Fibers of Poly(glycerol sebacate) and Poly(ε-caprolactone) for Cardiac Patch Application 68
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 67
Mobilization of cardiac progenitor cells by hepatocyte growth factor and insulin-like growth factor-1 for repairing chronic myocardial infarction is not proarrhythmic. 65
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 65
Studio del potenziale cardiogenico in vitro di monocolture e cocolture di cellule miocardiche e midollari 63
SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells 63
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 63
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 62
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 61
Rigenerazione miocardica mediata da cellule staminali: potenziale endogeno e fonti extracardiache 60
Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? 60
Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats 60
High-resolution X-ray microtomography for three-dimensional visualization of Cardiac Progenitor Cells Homing in infarcted rat hearts. 58
Rigenerazione mediata da cellule staminali: potenziale endogeno e fonti extracardiache 57
Early antioxidant treatment with resveratrol: a new therapeutic approach for preventing diabetic cardiomyopathy 57
Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment 57
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 57
Il potenziale rigenerativo miocardico di cellule umane di diversa origine 56
QUALI CELLULE UTILIZZARE PER LA RIGNERAZIONE DEL MIOCARDIO? 56
Uso di microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in modelli di ratto di infarto miocardico 55
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells 55
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 54
Il Cuore, il Midollo Osseo e la Placenta come fonti di terapia cellulare per la rigenerazione cardiaca 54
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 52
GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy 51
Pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors in myocardial regeneration 51
Influence of injectable microparticle size on cardiac progenitor cell response 50
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 49
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 48
Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. 48
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 47
Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processes 46
Detection of DNA strand breaks and cell death as individual predictive response to Gemtuzumab Ozogamicin in Acute Myeloid Leucemia 45
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 44
Isolation and Characterization of Cardiogenic Cells from the Adult Hypertrophic Human Heart 44
IDENTIFICATION OF HUMAN UNSELECTED MESENCHYMAL-LIKE MYOCARDIAL CELLS: Stem Cells for Myocardial Regeneration 43
Is there a way to predict the clinical outcome of DNA strand breaks generating drugs? The case of calicheamicin 42
In vitro cardiogenic potential of human myocardial and marrow stromal cells. 41
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 40
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 40
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 40
DETECTION OF DNA STRAND BREAK AS INDIVIDUAL PREDICTIVE RESPONSE TO GEMTUZUMAB OZOGAMICIN IN ACUTE MYELOID LEUKEMIA 38
Totale 7.653
Categoria #
all - tutte 27.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020916 0 0 0 26 96 214 164 29 139 140 37 71
2020/2021729 11 65 32 20 92 32 73 40 173 46 116 29
2021/2022510 26 16 15 25 14 12 71 57 22 36 28 188
2022/20232.447 250 268 180 179 248 269 38 140 717 9 110 39
2023/2024943 47 79 24 16 77 235 87 76 28 62 101 111
2024/2025383 43 128 162 50 0 0 0 0 0 0 0 0
Totale 7.838